Pharma fraud
Pharma Fraud
Pharma Fraud (pronunciation: /ˈfɑːrmə frɔːd/) is a term used to describe fraudulent activities committed within the pharmaceutical industry. These activities can range from misrepresentation of drug efficacy and safety, price gouging, to bribery and corruption in the drug approval process.
Etymology
The term "Pharma Fraud" is a combination of the words "Pharmaceutical" and "Fraud". "Pharmaceutical" is derived from the Greek word "Pharmakeia" which means "drug", while "Fraud" comes from the Latin word "fraus" meaning "deceit".
Related Terms
- Off-label marketing: This refers to the promotion of pharmaceuticals for an unapproved indication or in an unapproved age group, dosage, or route of administration.
- Kickbacks: This is a form of negotiated bribery in which a commission is paid to the bribe-taker in exchange for services rendered.
- Counterfeit drugs: These are fake pharmaceuticals which may be contaminated or contain the wrong or no active ingredient at all. They could have the right active ingredient but at the wrong dose.
- Data manipulation: This involves altering, inflating, or omitting data or results in clinical trials to make a drug appear safer or more effective than it actually is.
See Also
External links
- Medical encyclopedia article on Pharma fraud
- Wikipedia's article - Pharma fraud
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski